B Cell Lymphoma
News
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemia
The presence of “many or very many nevi [moles]” was particularly associated with the risk of CLL.
Conference Coverage
CAR T for all R/R DLBCL patients: The jury is still out
Article
Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate
Article
Efforts to close the ‘AYA gap’ in lymphoma
News
Seven things to know about new lymphoma drug tafasitamab
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
News
Napabucasin suppressed tumor growth in DLBCL cell lines
Napabucasin suppressed tumor growth, decreased Ki67 and CD31 and increased cleaved caspase-3.
News
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
News
FDA approves new drug for diffuse large B-cell lymphoma
News
HSCT or systemic treatment should be offered to HIV+ patients with lymphoma